NeuroOne Medical (NMTC) Technologies announced that Clara – an early patient treated with the Company’s patented OneRF Ablation System – has successfully surpassed the one year milestone of being seizure free. “This milestone further validates the intended benefits of our OneRF platform. Our next step is to leverage the technology for other applications, including our OneRF Trigeminal Nerve Ablation System to treat facial pain, for which we filed a 510(k) submission to the FDA in April 2025,” said Dave Rosa, CEO of NeuroOne.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMTC: